Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	756	297	213	707	2,006	1,242	695
Market Cap Growth	-	39.61%	-69.88%	-64.73%	61.56%	78.51%	-
Enterprise Value	679	220	109	530	1,895	1,037	548
PE Ratio	-13.88	-13.88	-2.23	-12.80	-16.81	-15.32	-16.07
PS Ratio	8.92	3.51	3.27	20.27	96.67	-	-
PB Ratio	7.49	2.95	1.95	3.93	18.95	6.24	4.95
P/FCF Ratio	-10.92	-10.92	-2.81	-17.17	-21.94	-16.45	-16.77
P/OCF Ratio	-10.92	-10.92	-2.81	-6.90	-21.99	-16.89	-16.87
EV/Sales Ratio	8.01	2.60	1.67	15.17	91.33	-	-
EV/EBITDA Ratio	-8.83	-8.83	-1.16	-10.06	-15.85	-12.51	-12.68
EV/EBIT Ratio	-8.58	-8.58	-1.15	-9.91	-15.80	-12.49	-12.67
EV/FCF Ratio	-8.09	-8.09	-1.44	-12.85	-20.73	-13.74	-13.21
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.04	0.01	-
Debt / EBITDA Ratio	-0.06	-0.06	-0.02	-0.07	-0.03	-0.03	-
Debt / FCF Ratio	-0.05	-0.05	-0.02	-0.09	-0.04	-0.03	-
Quick Ratio	5.02	5.02	4.18	6.79	5.87	15.25	16.21
Current Ratio	5.52	5.52	4.61	7.26	6.26	15.60	16.61
Asset Turnover	0.64	0.64	0.41	0.14	0.13	0	0
Interest Coverage	-	-	-125.25	-28.85	-	-	-982.50
Return on Equity (ROE)	-20.70%	-20.70%	-75.50%	-25.20%	-87.80%	-62.50%	-38.90%
Return on Assets (ROA)	-16.30%	-16.30%	-59.60%	-22.40%	-75.00%	-55.30%	-35.50%
Return on Capital (ROIC)	-25.07%	-25.07%	-85.42%	-62.82%	-109.22%	-41.27%	-30.76%
Earnings Yield	-2.83%	-7.20%	-44.85%	-7.81%	-5.95%	-6.53%	-6.22%
FCF Yield	-3.60%	-9.15%	-35.63%	-5.83%	-4.56%	-6.08%	-5.96%
Buyback Yield / Dilution	0.13%	0.13%	-1.21%	-7.64%	-14.03%	-22.28%	-48.33%
Total Shareholder Return	0.13%	0.13%	-1.21%	-7.64%	-14.03%	-22.28%	-48.33%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).